High glucose and interleukin-1β downregulate interleukin-1 type I receptor (IL-1RI) in retinal endothelial cells by enhancing its degradation by a lysosome-dependent mechanism
- 31 March 2010
- journal article
- research article
- Published by Elsevier BV in Cytokine
- Vol. 49 (3), 279-286
- https://doi.org/10.1016/j.cyto.2009.11.014
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Determination of vitreous interleukin-1 (IL-1) and tumour necrosis factor (TNF) levels in proliferative diabetic retinopathyEye, 2005
- Peroxynitrite Is a Potent Inhibitor of NF-κB Activation Triggered by Inflammatory Stimuli in Cardiac and Endothelial Cell LinesPublished by Elsevier BV ,2005
- Expression of Acute-Phase Response Proteins in Retinal Müller Cells in DiabetesPublished by Association for Research in Vision and Ophthalmology (ARVO) ,2005
- Role of Interleukin-1β in the Development of Retinopathy in Rats: Effect of AntioxidantsPublished by Association for Research in Vision and Ophthalmology (ARVO) ,2004
- Role of interleukin-1 in the pathogenesis of diabetic retinopathyBritish Journal of Ophthalmology, 2004
- Rat brain vascular distribution of interleukin‐1 type‐1 receptor immunoreactivity: Relationship to patterns of inducible cyclooxygenase expression by peripheral inflammatory stimuliJournal of Comparative Neurology, 2004
- Nonsteroidal anti‐inflammatory drugs prevent early diabetic retinopathy via TNF‐α suppressionThe FASEB Journal, 2002
- Interleukin 1 in the brain: biology, pathology and therapeutic targetTrends in Neurosciences, 2000
- The Effect of Cytokine Stimulation on IL-1 Receptor mRNA Expression by Intestinal Epithelial CellsCellular Immunology, 1996
- Detection and characterization of high affinity plasma membrane receptors for human interleukin 1.The Journal of Experimental Medicine, 1985